Claudia P. Miller - Concepedia

Author

Claudia P. Miller

The University of Texas MD Anderson Cancer Center

Also Known As

C. Miller, C. P. Miller, Claudia Miller, Claudia P Miller, Claudia P. Miller, Jinghui Zhang

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center United States Food and Drug Administration Center for Drug Evaluation and Research

About

Claudia P. Miller is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and apoptosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	344
2	Cell Biology	4	4	140
3	Health Sciences	1	1	149
4	Natural Sciences	1	1	22
5	Diagnostic Sciences	1	1	149

Claudia P. Miller

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma Barbara S. Paugh, Alberto Broniscer, Chunxu Qu, Journal of Clinical Oncology	2011	321
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells Claudia P. Miller, Kechen Ban, Melanie Dujka, Blood	2007	203
CXCL-12/Stromal Cell–Derived Factor-1α Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation Neslihan Cabıoğlu, Justin M. Summy, Claudia P. Miller, Cancer Research	2005	157
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors Jaleh Fallah, Michael H. Brave, Chana Weinstock, Clinical Cancer Research Surgical OncologyRenal PathologyPathologyPharmacotherapyNeuro-oncology	2022	149
Exposure of Melanoma Cells to Dacarbazine Results in Enhanced Tumor Growth and Metastasis In Vivo Dina Lev, Amir Onn, Vladislava O. Melinkova, Journal of Clinical Oncology	2004	129
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target Geoffrey Grandjean, Petrus R. de Jong, Brian P. James, Cancer Research	2016	78
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells Claudia P. Miller, Sharmistha Rudra, Michael J. Keating, Blood	2009	65
FDA Approval Summary: Dabrafenib in Combination with Trametinib for <i>BRAF</i>V600E Mutation–Positive Low-Grade Glioma Michael I. Barbato, Jeannette Nashed, Diana Bradford, Clinical Cancer Research	2023	59
BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia Kechen Ban, Yin Gao, Hesham M. Amin, Blood	2008	58
Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy Dina Chelouche‐Lev, Claudia P. Miller, Carmen S. Tellez, European Journal of Cancer Breast OncologyMedicineImmunologyCancer GrowthBreast Cancer	2004	56

Page 1